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Background: The concept of metabolic syndrome (MetS) was initially designed for long-term outcome
prediction in middle aged or younger individuals, but it is unclear whether MetS can be applied in older
people. We explored the clinical utility of MetS for prediction of various outcomes in older people. First,
we investigated whether MetS is associated with CVD and DM in the short term. Second, we took
multiple chronic illnesses into consideration to examine whether MetS is associated with increased
physical limitations.
Methods: Participants were selected from the “Social Environment and Biomarkers of Aging Study, 2000”
and the “2003 Survey of Health and Living Status of the Middle-Aged and Elderly in Taiwan” aged 65
years for whom complete data were available. A total of 543 older Taiwanese were included.
Results: For older people who had MetS compared to those without the syndrome in 2000, the risk of
CVD was 1.94 times higher in 2003 (p< 0.01) and that of DM was 3.02 times higher in 2003 (p< 0.01)
after controlling for age, sex, and chronic illnesses. Hierarchical regression models of physical functions
showed that MetS did not increase the explained variance in physical functional limitations.
Conclusions: MetS has short-term (3 years) effects on CVD and DM. After taking chronic illnesses into
consideration, no association between MetS and physical functioning was obvious. More studies are
needed to clarify the relationship among MetS, chronic illnesses, and physical functioning.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
The metabolic syndrome (MetS) is generally characterized as
a clustering of abnormal blood lipid levels, impaired fasting glucose,
elevated blood pressure, and obesity1. The term MetS is used to
identify people who are at higher risk of cardiovascular disease
(CVD) and diabetes mellitus (DM)2. Results from cross-sectional
studies have shown that MetS prevalence increases dramatically
with age3. The prevalence ranges from 5.2% in those aged 20e29
years to 36.5% in those aged 70e79 years in Taiwan4. These results
imply that MetS is an important issue for older populations.
However, the concept of MetS was initially designed for long-term
prediction of CVD or DM in middle-aged or younger individuals5.
If this approach was applied to older people, two problems couldouth Hall, Department of
n.
erest.
iwan Society of Geriatric Emergenoccur. First, aging per se is associated with increased incidence and
prevalence of CVD, DM, and other chronic illnesses. Approximately
70% of older Taiwanese have one or more chronic illnesses, for
whom medications and lifestyle changes are primary treatment
approaches. For those who already have CVD or DM, there is no
further recommendation for additional MetS diagnosis. Thus, the
concept of MetS is only applicable to older people without chronic
illnesses. Even for elderly individuals without chronic illnesses,
owing to their limited life expectancy, use of long-term predictors
might not be suitable for this population.
Some researchers have claimed that, in addition to predicting
CVD and DM, MetS is associated with a decline in physical func-
tions. For example, obesity, one of the features of MetS, is inde-
pendently and directly related to mobility and functional declines6.
High levels of glucose might cause microvascular impairment in
some people with MetS and worsen their physical functions7.
Empirical studies have shown that MetS is associated with physical
functional dependence in elderly populations8e11. Blazer et al
claimed that MetS might be a risk factor for mobility decline incy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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found that MetS was signiﬁcantly associated with ADL and IADL
dependence in older people9. Thus, the concept of MetS seems to be
suitable for predicting physical functional decline in older people.
However, none of these studies took into consideration other
chronic illnesses, such as arthritis or hip fracture, that might impair
physical functions. Studies with a higher degree of statistical
control over chronic illnesses are needed to clarify the association
between MetS and functional decline in older populations.
In general, the clinical value of MetS in older populations is
unclear12. Considering the limited life expectancy of older people,
we used short-term follow-up data to investigate the clinical utility
of MetS in older people. First, we examined whether MetS is
associated with CVD and DM. Second, we examined the correlation
between MetS and physical functions. In addition to CVD and DM,
we simultaneously considered multiple chronic illnesses related to
functional limitations to investigate whether MetS is associated
with increased physical limitation in older Taiwanese individuals.
2. Methods
The data were taken from The Social Environment and
Biomarkers of Aging Study (SEBAS, 2000)13 and The Survey of
Health and Living Status of the Middle-Aged and Elderly in Taiwan
(TLSA, 2003)14. Both SEBAS and TLSA included face-to-face inter-
views to gather data on demographics, physical functioning, and
history of chronic illnesses. SEBAS also included a medical exami-
nation and measurement of biomarkers to supplement the inter-
view data. SEBAS was approved by the institutional review board at
the National Institute of Family Planning in Taiwan.
People aged 65 years with blood sample in 2000, history of
chronic diseases, and complete data on mobility, activities of daily
living (ADL) and instrumental activities of daily living (IADL) were
included in this study. Among the SEBAS participants, 559
were 65 years and were followed up in TLSA. Of these, 15 were
excluded from our study owing to insufﬁcient data (1 for waist
circumference in 2000, 7 for mobility in 2000, 1 for ADL in 2000, 5
for IADL in 2000, 2 for mobility in 2003). Thus, 543 older Taiwanese
(215 females) were eligible for our study. The average age was
73.9 5.4 years (range 65e98 years).
2.1. Metabolic syndrome
The presence of MetS at baseline was assessed according to
NCEP ATP-III with modiﬁed criteria on waist circumference for
Asians15. There are ﬁve components in the deﬁnition: abdominal
obesity (waist circumference 90 cm in men, 80 cm in women),Table 1
Characteristics of the study sample in 2000 and 2003.
Year 2000
MetS Non-MetS
Participants (n) 221 322
Female (%) 56.6 28.0**
Age (y) 74.18 5.56 73.73 5.24
Mobility 5.73 6.22 3.56 4.53**
ADL 0.34 1.80 0.05 0.29*
IADL 2.28 3.75 1.23 2.48**
CVD (%) 61.1 41.6**
DM (%) 31.2 4.6**
Other chronic illness (%)a 72.4 71.4
*p< 0.01; **p< 0.001.
ADL¼ activities of daily living; CVD¼ cardiovascular disease, including high blood pressu
of daily living; MetS¼metabolic syndrome.
a Other chronic illnesses included cancer or malignant tumor, liver or gall bladder di
fracture, cataracts, gout, and a spinal or vertebral spur.elevated triglycerides (150 mg/dL), low high-density lipoprotein
cholesterol (<40 mg/dL in men, <50 mg/dL in women), elevated
blood pressure (systolic blood pressure 130 mmHg or diastolic
blood pressure 85 mmHg, or on antihypertensive drug treat-
ment), and elevated fasting glucose ( 100 mg/dL or on drug
treatment for elevated glucose). A diagnosis of MetS is made if at
least three criteria are met.
2.2. Physical functional indexes
Physical functioning was assessed in terms of mobility, ADL, and
IADL. All items were rated on a scale from 0 (no problem) to 3
(cannot perform alone). Mobility was assessed in terms of subjec-
tive difﬁculties in various physical tasks using nine items (e.g.,
squatting, walking 200e300 m). ADL relates to subjective difﬁcul-
ties in meeting various personal care needs and was assessed using
six items (e.g., eating, going to the toilet). IADL relates to subjective
difﬁculties in various activities necessary for maintaining a living
environment. It was assessed using six items (e.g., buying personal
items, traveling by bus). Composite variables were constructed to
create a mobility score (range of 0e27), an ADL score, and an IADL
score (range of 0e18 for both). Higher scores correspond to greater
limitations in physical functioning.
2.3. Self-reported history of chronic illness
Eight out of the 14 conditions listed in the interview question-
naire for history of chronic illnesses were selected from the top 10
leading causes of death in Taiwan: cancer or malignant tumor,
stroke (cerebral hemorrhage), CVD, DM, liver or gall bladder
disease, kidney disease, and lower respiratory tract disease. The
remaining six conditions on the list are likely to cause considerable
physical discomfort, including: arthritis or rheumatism, hip frac-
ture, cataracts, gout, and a bone spur.
3. Results
The MetS prevalence was 40.7% in the cohort. Table 1 lists data
on sex, age, prevalence of chronic illnesses, and physical func-
tioning for the study participants. On average, each participant had
2.2 chronic diseases before 2000. Only 81 of the participants had no
chronic illness in 2000. The prevalence signiﬁcantly differed
between participants with and without MetS for CVD in 2000
(c2¼19.88, p< 0.001) and DM in 2000 (c2¼ 70.72, p< 0.001).
Most of the participants with MetS also had chronic illnesses. The
mean baseline physical functional scores in 2000 were 4.44 5.38




t¼ 4.72 6.68 6.93 5.58 6.51** t¼ 4.51
t¼ 2.92 0.85 2.97 0.66 2.67 t¼ 1.84
t¼ 3.91 3.03 4.80 2.37 4.38** t¼ 3.91
c2¼ 19.88 69.2 47.2** c2¼ 25.83
c2¼ 70.72 33.9 6.5** c2¼ 67.68
c2¼ 0.06 81.4 74.5 c2¼ 3.58
re, heart disease, and stroke; DM¼ diabetes mellitus; IADL¼ instrumental activities
sease, kidney disease, lower respiratory tract disease, arthritis or rheumatism, hip
Table 2
Multivariate-adjusted hazard ratio (95% conﬁdence interval) for the metabolic syndrome in relation to incident CVD, stroke and DM over 3 years of follow-up.
Incident CVD Incident DM
Model 1 Model 2 Model 1 Model 2
Age 1.04 (1.00e1.09)* 1.04 (1.00e1.09)* 1.01 (0.94e1.07) 1.01 (0.94e1.07)
Sex 1.30 (0.84e2.01) 1.10 (0.70e1.73) 1.22 (0.61e2.45) 0.93 (0.45e1.93)
CVD in 2000 14.72 (9.53e22.73)*** 14.10 (9.11e21.83)*** 1.13 (0.56e2.26) 0.99 (0.49e2.02)
DM in 2000 1.28 (0.69e2.37) 0.95 (0.50e1.83) 104.78 (49.04e223.83)*** 79.58 (36.72e172.47)***
Other chronic illnesses in 2000a 1.00 (0.62e1.59) 1.03 (0.64e3.15) 0.67 (0.32e1.42) 0.68 (0.32e1.46)
MetS in 2000 1.94 (1.20e3.15)** 3.02 (1.44e6.36)**
*p< 0.05; **p< 0.01; ***p< 0.001.
CVD¼ cardiovascular disease, including high blood pressure, heart disease, and stroke; DM¼ diabetes mellitus; MetS¼metabolic syndrome.
a Other chronic illnesses included cancer or malignant tumor, liver or gall bladder disease, kidney disease, lower respiratory tract disease, arthritis or rheumatism, hip
fracture, cataracts, gout, and a spinal or vertebral spur.
Table 3




Mobility 2003 ADL 2003 IADL 2003
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Sex 0.23*** 0.22*** 0.01 0.01 0.21*** 0.20***
Age 0.23*** 0.23*** 0.17*** 0.17*** 0.30*** 0.30***
CVD at 2000 0.01 0.02 0.02 0.02 0.01 0.01




0.10* 0.10* 0.01 0.01 0.02 0.02
MetS 0.04 0.01 0.03
Total R square 0.19 0.19 0.05 0.05 0.18 0.18
*p< 0.05; **p< 0.01; ***p< 0.001.
ADL¼ activities of daily living; CVD¼ cardiovascular disease, including high blood
pressure, heart disease, and stroke; DM¼ diabetes mellitus; IADL¼ instrumental
activities of daily living; MetS¼metabolic syndrome.
a Other chronic illnesses included cancer or malignant tumor, liver or gall bladder
disease, kidney disease, lower respiratory tract disease, arthritis or rheumatism, hip
fracture, cataracts, gout, and a spinal or vertebral spur.
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MetS for mobility (p< 0.001), ADL (p< 0.05), and IADL (p< 0.001).
Participants without MetS had less physical functional limitations
at baseline. Only 66 (14.8%) of the participants had no chronic
illness in 2003. The mean score for the overall sample was
6.68 6.93 for mobility, 0.85 2.97 for ADL, and 3.03 4.80 for
IADL. There were signiﬁcant differences between participants with
and without MetS in the prevalence of chronic illnesses, mobility,
and IADL.
Table 2 shows themultivariate-adjusted hazard ratio for MetS in
relation to CVD and DM in 2003. Age is strongly associated with
CVD, but is weakly or not associated with DM. After controlling for
age, sex, and chronic illnesses in 2000, the risk of developing CVD in
2003 was 1.94 times higher in participants with MetS compared to
those without MetS in 2000 (p< 0.01). The result for DM was
similar. The DM hazard ratio in 2003 was 3.02 in participants who
had MetS in 2000 (p< 0.01).
Hierarchical regression models of physical functioning are pre-
sented in Table 3. The models show that age and DM in 2000 can
signiﬁcantly predict mobility, ADL, and IADL in 2003 (all p< 0.001).
Other chronic illnesses in 2000 can signiﬁcantly predict mobility in
2003 (p< 0.05), but not ADL and IADL. After controlling for age, sex,
and chronic illnesses in 2000, MetS did not increase the explained
variance in mobility, ADL, and IADL in 2003.
4. Conclusions
According to our results, MetS cannot be used to predict the
incidence of CVD or DM in the short term. The utility of MetS should
bemore feasible in predicting physical functional decline. However,our results show that MetS was associated with CVD and DM three
years after the identiﬁcation. After considering function-impairing
chronic illnesses, we did not ﬁnd any signiﬁcant association
between MetS and physical functional limitations. Most studies of
MetS predicting CVD and DM looked at an interval of more than 10
years. To the best of our knowledge, only one study explored the
relationship between MetS and the incidence of CVD and other
chronic diseases in the short term, and no correlation between
MetS and CVD was found in non-diabetic older people16. Since
older peoplewithout diabetes have relatively healthier lifestyle, the
study samplemight not be a good representation of the entire older
population. The external validity of the study is limited. We used
a nationally representative sample and statistically controlled for
the presence of chronic illnesses. The results show that MetS is
associated with CVD and DM in older Taiwanese individuals.
Therefore, MetS in older people is still worthy of attention.
Some previous studies have shown an association between
MetS and physical functional dependence in older people.
However, none of these studies took other function-impairing
chronic illnesses into consideration. According to our results, DM
has salient effects on physical functioning. Older people with dia-
betes not only have more limited mobility, but also have more
difﬁculties in self-care. Other chronic illnesses limit only mobility
and not self-care abilities. After controlling for chronic illnesses, we
found hardly any association betweenMetS and physical functional
limitations. Therefore, in terms of preventing disabilities, the
effects of chronic illnesses should be considered more seriously.
Ideally, the use of older people without CVD or DM as a study
population could produce more powerful evidence to clarify the
association between MetS and CVD or DM. However, only a small
proportion of the elderly do not have CVD or DM. In the present
study, only 246 (45.3%) participants werewithout CVD and DM, and
among them, only 63 (25.6%) met theMetS criteria. The low sample
number and uneven distribution might diminish the power of the
ﬁndings in this study. Furthermore, older people without CVD or
DMmight have different lifestyles from thosewho have CVD or DM.
A rigorous sampling strategy would lower the external validity and
there would be more limitations in applying the study results. We
controlled for the presence of CVD and DM to maintain the repre-
sentativeness of the sample statistically. The results show thatMetS
is associated with CVD and DM over a period of 3 years. In other
words, if older people meet the MetS criteria, they have a signiﬁ-
cantly higher chance of developing CVD or DM within 3 years.
Therefore, active intervention to prevent CVD and DM is warranted
for older people with MetS.
According to our results, MetS has a weak or no association
with physical functional limitations after controlling for chronic
illnesses. The results do not support a direct correlation between
MetS and functional decline in older people. The ﬁndings seem to
imply that a complex relationship exists among MetS, chronic
illnesses, and physical functioning. More research is needed to
Clinical Utility of Metabolic Syndrome for Older Taiwanese 149clarify the association between MetS, chronic illnesses, and func-
tional decline, and to explore the underlying mechanisms.
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